About Ventana
Ventana is a Healthcare company based in Tucson (United States) founded in 1985, and was acquired by Roche in June 2007. Ventana Medical Systems Inc, a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining. The company has 1,152 employees. Ventana has completed 1 acquisition, including Spring Bioscience. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is VENTANA MEDICAL SYSTEMS, INC. Its competitors include Guardant Health, Foundation Medicine and ArcherDX; 3 of its 3 listed competitors have raised funding.
Company details
Ventana Medical Systems, Inc. offers histology and pathology labs increased efficiency with automated HE, immunohistochemistry (IHC), in situ hybridization (ISH) stainers and workflow management solutions. Slide-based tissue diagnostics support diagnosis and inform cancer treatment decisions.
- Headquarters Tucson, United States
- Employees 1,152
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website ventana.com
- Social X
- Acquired by Roche (Jun 2007)
- Legal Name Ventana Medical Systems, Inc.
Funding Insights of Ventana
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Ventana with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2012 | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Ventana
Ventana has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche and Point Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Lease financing is provided to growth-stage companies in the US. | pointfin.com | Phoenix, United States | ||
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | roche.com | Basel, Switzerland |
Investor details for Ventana
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ventana
82 people are tracked at Ventana (9 in leadership, 73 in team); the tracked headcount is 1,152.
| Name | Role | Group |
|---|---|---|
Sanket Unhale | Director And Project Leader, Cdx | Leadership |
Sebastiaan la Bastide | Head Of Strategy & Lifecycle Services | Leadership |
Jim Danehy | Chief Executive Officer | Leadership |
Himanshu Parikh | Vice President - Operations, Tissue Diagnostics & Sequencing Unit | Leadership |
Bryan Roland | Senior Director - Project Leader Companion Diagnostics | Leadership |
Trevor White | Head Of Marketing | Leadership |
Timothy Hubbard | Director Operations Quality | Leadership |
Sean Moran | Director, Companion Diagnostics Project Lead | Leadership |
Iqbal Zaidi | Director Of Operations, Roche Tissue Diagnostics | Leadership |
Bohuslav Dvorak | Staff Scientist | Team |
Mary Raye Hestand | Technical Support Specialist Senior | Team |
Mert Colpan | Pharma Services Scientist | Team |
Ryan Miller | Senior Scientist | Team |
Zhiming Liao M.D. | Oncology Biomarker Lead/pathologist | Team |
Delia Garcia | Senior Histotechnology Specialist | Team |
Lonnie Hetschel | Scientist | Team |
Tom Taylor | Sub Chapter Lead - R&d Services | Team |
Richard Powers | Lead Systems Engineer, Advanced Staining Platforms | Team |
Julia Ashworth-Sharpe | Senior Scientist | Team |
Julia Sharpe | Sr Scientist | Team |
62 more people are available in the full profile.
Complete people profiles for Ventana
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ventana
Ventana has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Spring Bioscience.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Immunohistochemistry (IHC) products with focus on monoclonal antibodies. | springbio.com | Pleasanton, United States | 2001 | Sep 2007 | $28.9M |
Complete acquisition details for Ventana
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ventana
4 dated milestones of Ventana across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Ventana is founded.
- Exit Acquired by Roche.
- Acquisition Acquires Spring Bioscience.
- Funding First funding round.
Competitors of Ventana
Ventana has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, Foundation Medicine and ArcherDX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. |
Detailed competitors of Ventana
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ventana
Websites that share an audience with Ventana (ventana.com).
- Global rank#13,526,773
among all websites
- Category rank#8,450
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.5
- Average visit36 sec
- DevicesDesktop 28% · Mobile 72%
Websites whose visitors overlap most with Ventana. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cellmarque.com | 100% | 20.5K | #2,261,189 | View details | |
| dako.com | 73% | 1.6K | #11,422,431 | View details | |
healthcarecomm.org | healthcarecomm.org | 47% | – | ||
| sonichealthcare.com | 46% | 454.2K | #103,632 | View details | |
| ameripath.com | 46% | 12.5K | #1,998,106 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Ventana
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical Genomics
3 companies that operate in the same segment as Ventana (Clinical Genomics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ventana
Complete news archive for Ventana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ventana
Ventana was founded in 1985 and raised its 1st funding round 27 years after it was founded.
Ventana is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.
Ventana has 1,152 employees.
Ventana Medical Systems, Inc. offers histology and pathology labs increased efficiency with automated HE, immunohistochemistry (IHC), in situ hybridization (ISH) stainers and workflow management solutions. Slide-based tissue diagnostics support diagnosis and inform cancer treatment decisions.
Ventana's top competitors include Guardant Health, Foundation Medicine and ArcherDX.
Ventana has made 1 acquisition, including Spring Bioscience.
Ventana has 2 investors. Key investors include Roche, and Point Financial.
Ventana operates through Ventana Medical Systems, Inc..
Yes. Ventana was acquired by Roche in June 2007.